{"hands_on_practices": [{"introduction": "A crucial step in drug development is predicting how quickly the human body will eliminate a new chemical entity. This process often begins in the laboratory. This exercise will guide you through a fundamental technique in pharmacokinetics, demonstrating how kinetic parameters like $V_{\\max}$ and $K_m$ measured from in vitro experiments with liver enzymes can be scaled up to predict the total metabolic clearance capacity of the entire liver. Mastering this in vitro-in vivo extrapolation is essential for forecasting a drug's behavior in patients based on preclinical data. [@problem_id:4942705]", "problem": "A uridine 5'-diphospho-glucuronosyltransferase 2B7 (UGT2B7)-mediated glucuronidation assay is performed using pooled human liver microsomes. The reaction velocity for the formation of the glucuronide of a xenobiotic substrate follows the Michaelis–Menten relationship, where the initial rate $v$ depends on substrate concentration $C$ according to a saturable enzyme process. In vitro kinetic parameters measured under steady-state conditions are $V_{\\max} = 275\\ \\mathrm{pmol}\\ \\mathrm{min}^{-1}\\ \\mathrm{mg}^{-1}$ and $K_{m} = 22\\ \\mathrm{\\mu M}$. The microsomal protein per gram of liver (MPPGL) is $40\\ \\mathrm{mg}\\ \\mathrm{g}^{-1}$, and the liver mass is $1400\\ \\mathrm{g}$. Assume that, for the purpose of defining intrinsic clearance, the substrate concentration in vivo is sufficiently low relative to $K_{m}$ such that the initial slope of the rate versus concentration relationship determines the intrinsic clearance per unit microsomal protein, and that binding in the incubation does not restrict the enzyme-accessible concentration.\n\nStarting from the fundamental definition of the Michaelis–Menten rate law and the definition of intrinsic clearance as the limiting value of $v/C$ as $C \\to 0$, derive the intrinsic clearance per milligram of microsomal protein and scale it to whole-liver intrinsic clearance using the provided microsomal protein per gram of liver and liver mass. Convert all quantities to provide the final hepatic intrinsic clearance in $\\mathrm{L}\\ \\mathrm{h}^{-1}$. Round your final answer to three significant figures.", "solution": "The problem requires the derivation and calculation of the total hepatic intrinsic clearance from in vitro kinetic data. The process involves three main steps: first, deriving the expression for intrinsic clearance per unit of microsomal protein from the Michaelis–Menten equation; second, scaling this value to the entire liver; and third, converting the units to the required format.\n\nThe initial rate of reaction, $v$, as a function of substrate concentration, $C$, is given by the Michaelis–Menten equation:\n$$v = \\frac{V_{\\max} C}{K_m + C}$$\nHere, $V_{\\max}$ is the maximum reaction velocity per milligram of microsomal protein, and $K_m$ is the Michaelis constant. The given values are $V_{\\max} = 275\\ \\mathrm{pmol}\\ \\mathrm{min}^{-1}\\ \\mathrm{mg}^{-1}$ and $K_{m} = 22\\ \\mathrm{\\mu M}$.\n\nThe intrinsic clearance per milligram of microsomal protein, denoted as $CL_{int, \\mu}$, is defined as the ratio of the reaction velocity to the substrate concentration in the limit of very low substrate concentration, as stated in the problem. Mathematically, this is:\n$$CL_{int, \\mu} = \\lim_{C \\to 0} \\frac{v}{C}$$\nSubstituting the expression for $v$ into this definition:\n$$CL_{int, \\mu} = \\lim_{C \\to 0} \\frac{1}{C} \\left( \\frac{V_{\\max} C}{K_m + C} \\right)$$\nThe term $C$ in the numerator and denominator cancels out:\n$$CL_{int, \\mu} = \\lim_{C \\to 0} \\frac{V_{\\max}}{K_m + C}$$\nEvaluating the limit as $C$ approaches $0$ yields the expression for intrinsic clearance under first-order kinetic conditions:\n$$CL_{int, \\mu} = \\frac{V_{\\max}}{K_m}$$\nNow, we can substitute the provided numerical values. Before performing the division, we must ensure the units are consistent. The units of $V_{\\max}$ are amount per time per mass of protein, while the units of $K_m$ are concentration (amount per volume). We need to convert the concentration unit $\\mathrm{\\mu M}$ into units that are compatible with $\\mathrm{pmol}$.\n$1\\ \\mathrm{M} = 1\\ \\mathrm{mol}\\ \\mathrm{L}^{-1}$. Therefore, $1\\ \\mathrm{\\mu M} = 1\\ \\mathrm{\\mu mol}\\ \\mathrm{L}^{-1}$.\nLet's convert this to $\\mathrm{pmol}\\ \\mathrm{\\mu L}^{-1}$:\n$$1\\ \\mathrm{\\mu M} = \\frac{1\\ \\mathrm{\\mu mol}}{1\\ \\mathrm{L}} = \\frac{10^6\\ \\mathrm{pmol}}{10^6\\ \\mathrm{\\mu L}} = 1\\ \\mathrm{pmol}\\ \\mathrm{\\mu L}^{-1}$$\nSo, the value of $K_m$ can be expressed as:\n$$K_m = 22\\ \\mathrm{\\mu M} = 22\\ \\mathrm{pmol}\\ \\mathrm{\\mu L}^{-1}$$\nNow we can calculate $CL_{int, \\mu}$:\n$$CL_{int, \\mu} = \\frac{275\\ \\mathrm{pmol}\\ \\mathrm{min}^{-1}\\ \\mathrm{mg}^{-1}}{22\\ \\mathrm{pmol}\\ \\mathrm{\\mu L}^{-1}} = 12.5\\ \\mathrm{\\mu L}\\ \\mathrm{min}^{-1}\\ \\mathrm{mg}^{-1}$$\nThis is the intrinsic clearance per milligram of microsomal protein.\n\nThe next step is to scale this value up to the total hepatic intrinsic clearance, $CL_{int, H}$. This is done by multiplying $CL_{int, \\mu}$ by the amount of microsomal protein per gram of liver (MPPGL) and the total liver mass.\nThe given values are $\\mathrm{MPPGL} = 40\\ \\mathrm{mg}\\ \\mathrm{g}^{-1}$ and liver mass $= 1400\\ \\mathrm{g}$.\nThe scaling equation is:\n$$CL_{int, H} = CL_{int, \\mu} \\times \\mathrm{MPPGL} \\times \\mathrm{Liver\\ Mass}$$\nSubstituting the values:\n$$CL_{int, H} = (12.5\\ \\mathrm{\\mu L}\\ \\mathrm{min}^{-1}\\ \\mathrm{mg}^{-1}) \\times (40\\ \\mathrm{mg}\\ \\mathrm{g}^{-1}) \\times (1400\\ \\mathrm{g})$$\nThe units $\\mathrm{mg}$ and $\\mathrm{g}$ cancel out, leaving units of $\\mathrm{\\mu L}\\ \\mathrm{min}^{-1}$, which represents a total clearance for the organ.\n$$CL_{int, H} = 12.5 \\times 40 \\times 1400\\ \\mathrm{\\mu L}\\ \\mathrm{min}^{-1}$$\n$$CL_{int, H} = 500 \\times 1400\\ \\mathrm{\\mu L}\\ \\mathrm{min}^{-1}$$\n$$CL_{int, H} = 700000\\ \\mathrm{\\mu L}\\ \\mathrm{min}^{-1}$$\nThe final step is to convert the units of $CL_{int, H}$ from $\\mathrm{\\mu L}\\ \\mathrm{min}^{-1}$ to $\\mathrm{L}\\ \\mathrm{h}^{-1}$.\nWe use the conversion factors:\n$1\\ \\mathrm{L} = 10^6\\ \\mathrm{\\mu L}$\n$1\\ \\mathrm{h} = 60\\ \\mathrm{min}$\n$$CL_{int, H} = 700000\\ \\frac{\\mathrm{\\mu L}}{\\mathrm{min}} \\times \\left(\\frac{1\\ \\mathrm{L}}{10^6\\ \\mathrm{\\mu L}}\\right) \\times \\left(\\frac{60\\ \\mathrm{min}}{1\\ \\mathrm{h}}\\right)$$\n$$CL_{int, H} = \\frac{700000 \\times 60}{10^6}\\ \\mathrm{L}\\ \\mathrm{h}^{-1}$$\n$$CL_{int, H} = \\frac{42000000}{1000000}\\ \\mathrm{L}\\ \\mathrm{h}^{-1}$$\n$$CL_{int, H} = 42\\ \\mathrm{L}\\ \\mathrm{h}^{-1}$$\nThe problem requires the answer to be rounded to three significant figures. Therefore, the value is $42.0\\ \\mathrm{L}\\ \\mathrm{h}^{-1}$.", "answer": "$$\n\\boxed{42.0}\n$$", "id": "4942705"}, {"introduction": "Most drugs do not follow a single metabolic path; instead, they are often substrates for multiple competing enzymes. This practice explores how the principles of Michaelis-Menten kinetics govern this competition, determining which Phase II conjugation pathway—sulfation or glucuronidation—predominates at different drug concentrations. By working through the classic example of acetaminophen, you will gain a quantitative understanding of dose-dependent metabolism, a concept critical for predicting a drug's safety and efficacy. [@problem_id:4942686]", "problem": "Acetaminophen undergoes Phase II conjugation in the liver through two major pathways: sulfation catalyzed by Sulfotransferase Family 1A Member 1 (SULT1A1) and glucuronidation catalyzed by Uridine Diphosphate Glucuronosyltransferase Family 1 Member A6 (UGT1A6). Under conditions where the cosubstrates 3'-Phosphoadenosine-5'-Phosphosulfate (PAPS) for sulfation and Uridine Diphosphate Glucuronic Acid (UDPGA) for glucuronidation are saturating, and assuming a single-substrate regime, each pathway can be modeled by Michaelis–Menten kinetics. The foundational basis is that a single-substrate enzyme-mediated reaction at steady state follows the relation $v = V_{\\max}\\,\\frac{[S]}{K_{m} + [S]}$, where $v$ is the reaction velocity, $V_{\\max}$ is the maximal velocity, $K_{m}$ is the Michaelis constant, and $[S]$ is the substrate concentration. For acetaminophen concentrations $[A]$ (in $\\mathrm{mM}$), consider the following representative kinetic parameters measured per milligram of microsomal or cytosolic protein: SULT1A1 has $V_{\\max,S} = 4\\,\\mathrm{nmol\\,min^{-1}\\,mg^{-1}}$ and $K_{m,S} = 0.2\\,\\mathrm{mM}$; UGT1A6 has $V_{\\max,G} = 40\\,\\mathrm{nmol\\,min^{-1}\\,mg^{-1}}$ and $K_{m,G} = 3\\,\\mathrm{mM}$. Using these data and starting from the definition of Michaelis–Menten kinetics and the notion that the fraction of acetaminophen routed to sulfation equals the sulfation velocity divided by the sum of the sulfation and glucuronidation velocities, derive a simplified closed-form analytical expression for the fraction of acetaminophen conjugation flux directed to sulfation, denoted $f_{\\mathrm{sulf}}([A])$, as a function of $[A]$. Express your final answer as a single algebraic function of $[A]$ (with $[A]$ in $\\mathrm{mM}$), and give the fraction as a pure number with no units.", "solution": "The problem requires the derivation of an expression for the fraction of acetaminophen conjugation flux directed to sulfation, $f_{\\mathrm{sulf}}([A])$. This fraction is defined as the ratio of the sulfation velocity, $v_S$, to the total velocity of conjugation, which is the sum of the sulfation and glucuronidation velocities, $v_S + v_G$.\n\nLet $[A]$ be the concentration of acetaminophen. Both enzymatic reactions, sulfation and glucuronidation, are stated to follow Michaelis–Menten kinetics. The velocity of each pathway is given by the equation:\n$$v = V_{\\max}\\,\\frac{[S]}{K_{m} + [S]}$$\nwhere $[S]$ is the substrate concentration, in this case $[A]$.\n\nFor the sulfation pathway, catalyzed by SULT1A1, the reaction velocity $v_S$ is:\n$$v_S([A]) = V_{\\max,S}\\,\\frac{[A]}{K_{m,S} + [A]}$$\nThe given parameters are $V_{\\max,S} = 4\\,\\mathrm{nmol\\,min^{-1}\\,mg^{-1}}$ and $K_{m,S} = 0.2\\,\\mathrm{mM}$.\n\nFor the glucuronidation pathway, catalyzed by UGT1A6, the reaction velocity $v_G$ is:\n$$v_G([A]) = V_{\\max,G}\\,\\frac{[A]}{K_{m,G} + [A]}$$\nThe given parameters are $V_{\\max,G} = 40\\,\\mathrm{nmol\\,min^{-1}\\,mg^{-1}}$ and $K_{m,G} = 3\\,\\mathrm{mM}$.\n\nThe fraction of acetaminophen routed to sulfation, $f_{\\mathrm{sulf}}([A])$, is defined as:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{v_S([A])}{v_S([A]) + v_G([A])}$$\nSubstituting the Michaelis–Menten expressions for $v_S([A])$ and $v_G([A])$ into this definition yields:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{V_{\\max,S}\\,\\frac{[A]}{K_{m,S} + [A]}}{V_{\\max,S}\\,\\frac{[A]}{K_{m,S} + [A]} + V_{\\max,G}\\,\\frac{[A]}{K_{m,G} + [A]}}$$\nAssuming that the acetaminophen concentration $[A]$ is non-zero, we can divide the numerator and the denominator by $[A]$:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{\\frac{V_{\\max,S}}{K_{m,S} + [A]}}{\\frac{V_{\\max,S}}{K_{m,S} + [A]} + \\frac{V_{\\max,G}}{K_{m,G} + [A]}}$$\nTo simplify this complex fraction, we multiply the numerator and the denominator by the product of the inner denominators, $(K_{m,S} + [A])(K_{m,G} + [A])$:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{\\frac{V_{\\max,S}}{K_{m,S} + [A]} \\cdot (K_{m,S} + [A])(K_{m,G} + [A])}{(\\frac{V_{\\max,S}}{K_{m,S} + [A]} + \\frac{V_{\\max,G}}{K_{m,G} + [A]}) \\cdot (K_{m,S} + [A])(K_{m,G} + [A])}$$\nThis simplifies to:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{V_{\\max,S}\\,(K_{m,G} + [A])}{V_{\\max,S}\\,(K_{m,G} + [A]) + V_{\\max,G}\\,(K_{m,S} + [A])}$$\nNow, we substitute the provided numerical values for the kinetic parameters:\n$V_{\\max,S} = 4$\n$K_{m,S} = 0.2$\n$V_{\\max,G} = 40$\n$K_{m,G} = 3$\n\nThe units for $V_{\\max}$ are $\\mathrm{nmol\\,min^{-1}\\,mg^{-1}}$ and for $K_m$ and $[A]$ are $\\mathrm{mM}$. The units are consistent and will cancel out, resulting in a dimensionless fraction as required.\n\nSubstituting these values into the expression for $f_{\\mathrm{sulf}}([A])$:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{4\\,(3 + [A])}{4\\,(3 + [A]) + 40\\,(0.2 + [A])}$$\nExpanding the terms in the numerator and denominator:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{12 + 4[A]}{(12 + 4[A]) + (40 \\times 0.2 + 40[A])}$$\n$$f_{\\mathrm{sulf}}([A]) = \\frac{12 + 4[A]}{12 + 4[A] + 8 + 40[A]}$$\nCombining like terms in the denominator:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{12 + 4[A]}{20 + 44[A]}$$\nThe numerator and denominator share a common factor of $4$. Dividing both by $4$ gives the simplified closed-form analytical expression:\n$$f_{\\mathrm{sulf}}([A]) = \\frac{3 + [A]}{5 + 11[A]}$$\nThis expression gives the fraction of acetaminophen conjugation directed to sulfation as a function of the acetaminophen concentration $[A]$ in units of $\\mathrm{mM}$.", "answer": "$$\\boxed{\\frac{3+[A]}{5+11[A]}}$$", "id": "4942686"}, {"introduction": "While Phase II conjugation reactions are powerful detoxification mechanisms, the cellular co-substrates they rely upon are finite. This practice brings kinetics into a dynamic, real-world toxicological scenario: an acetaminophen overdose. You will construct a mathematical model to track the body's pool of the critical antioxidant glutathione (GSH) as it is consumed by a toxic metabolite, ultimately predicting the time window before this essential defense is completely depleted. [@problem_id:4942712]", "problem": "A high-dose acetaminophen exposure in a human adult causes extensive formation of N-acetyl-p-benzoquinone imine (NAPQI). In hepatocytes, NAPQI is detoxified via phase II conjugation with glutathione (GSH), catalyzed by glutathione S-transferase (GST). For the time window of interest, assume the following are true: (i) each mole of NAPQI conjugated consumes exactly one mole of GSH, (ii) the enzyme-catalyzed conjugation step is fast relative to pool dynamics such that every mole of NAPQI formed is immediately conjugated while GSH remains available, (iii) hepatic GSH is synthesized at a constant zero-order rate, and (iv) non-NAPQI uses of GSH follow first-order kinetics with respect to the GSH pool. Let the hepatic GSH pool be $G(t)$ with initial amount $G(0) = G_0$.\n\nParameters for this overdose scenario are:\n- Initial hepatic GSH stores $G_0 = 5.0\\ \\mathrm{mmol}$.\n- NAPQI formation rate $r_f = 0.080\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$.\n- Hepatic GSH synthesis rate $s = 0.010\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$.\n- Baseline (non-NAPQI) GSH turnover rate constant $k_d = 3.0 \\times 10^{-3}\\ \\mathrm{min}^{-1}$.\n\nStarting from mass balance and the stoichiometry of conjugation, derive the governing equation for $G(t)$ and solve for the time $T$ at which $G(T) = 0$ (complete depletion of hepatic GSH). Express the final time $T$ in hours, and round your final answer to three significant figures.", "solution": "The problem requires the derivation of a governing equation for the hepatic glutathione (GSH) pool, denoted by $G(t)$, and the calculation of the time $T$ at which this pool is completely depleted, i.e., $G(T) = 0$. The derivation begins with the principle of mass balance.\n\nThe rate of change of the GSH pool, $\\frac{dG}{dt}$, is the sum of its rate of synthesis and its rates of consumption. According to the problem statement:\n$1$. The rate of synthesis is a constant, zero-order process given by the rate $s$. This represents a positive contribution to $\\frac{dG}{dt}$.\n$2$. The rate of consumption for detoxifying N-acetyl-p-benzoquinone imine (NAPQI) is equal to the rate of NAPQI formation, $r_f$. This is because the conjugation is assumed to be immediate. The stoichiometry is $1$:$1$, so this process consumes GSH at a constant rate $r_f$. This represents a negative contribution to $\\frac{dG}{dt}$.\n$3$. The rate of consumption from baseline (non-NAPQI) uses follows first-order kinetics with respect to the GSH pool, $G(t)$. This is given by the rate $k_d G(t)$, where $k_d$ is the first-order rate constant. This is also a negative contribution to $\\frac{dG}{dt}$.\n\nCombining these terms, the mass balance equation for the GSH pool is:\n$$ \\frac{dG}{dt} = s - r_f - k_d G(t) $$\nThis is the governing ordinary differential equation (ODE) for $G(t)$. It is a first-order linear non-homogeneous ODE. The initial condition is given as $G(0) = G_0$.\n\nTo solve this ODE, we can rearrange it into the standard form $\\frac{dG}{dt} + k_d G(t) = s - r_f$.\nThis equation can be solved by separating variables. Let us group the constant terms $s$ and $r_f$. The equation is:\n$$ \\frac{dG}{dt} = (s - r_f) - k_d G $$\nWe separate variables as follows:\n$$ \\frac{dG}{(s - r_f) - k_d G} = dt $$\nWe integrate this equation from the initial time $t=0$ (where $G=G_0$) to the time $T$ (where $G=0$):\n$$ \\int_{G_0}^{0} \\frac{dG}{(s - r_f) - k_d G} = \\int_{0}^{T} dt $$\nThe integral on the right side is simply $T$. The integral on the left side is:\n$$ \\int_{G_0}^{0} \\frac{dG}{(s - r_f) - k_d G} = \\left[ -\\frac{1}{k_d} \\ln(|(s - r_f) - k_d G|) \\right]_{G_0}^{0} $$\nEvaluating at the limits of integration:\n$$ -\\frac{1}{k_d} \\left( \\ln(|s - r_f|) - \\ln(|(s - r_f) - k_d G_0|) \\right) = T $$\nWe can simplify the expression by rearranging the logarithm term:\n$$ T = \\frac{1}{k_d} \\left( \\ln(|(s - r_f) - k_d G_0|) - \\ln(|s - r_f|) \\right) $$\n$$ T = \\frac{1}{k_d} \\ln\\left(\\frac{|(s - r_f) - k_d G_0|}{|s - r_f|}\\right) $$\nGiven the parameters, $s - r_f = 0.010 - 0.080 = -0.070\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$, which is negative. Also, $(s - r_f) - k_d G_0 = -0.070 - (3.0 \\times 10^{-3})(5.0) = -0.070 - 0.015 = -0.085\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$, which is also negative. Thus, we can drop the absolute value bars by multiplying the arguments by $-1$:\n$$ T = \\frac{1}{k_d} \\ln\\left(\\frac{k_d G_0 - (s - r_f)}{-(s - r_f)}\\right) $$\n$$ T = \\frac{1}{k_d} \\ln\\left(\\frac{k_d G_0 + r_f - s}{r_f - s}\\right) $$\nThis expression gives the time $T$ for complete GSH depletion in symbolic form. Now we substitute the given numerical values:\n- $G_0 = 5.0\\ \\mathrm{mmol}$\n- $r_f = 0.080\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$\n- $s = 0.010\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$\n- $k_d = 3.0 \\times 10^{-3}\\ \\mathrm{min}^{-1}$\n\nFirst, we calculate the terms inside the logarithm:\n- $r_f - s = 0.080 - 0.010 = 0.070\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$\n- $k_d G_0 = (3.0 \\times 10^{-3}) \\times (5.0) = 0.015\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$\n- $k_d G_0 + r_f - s = 0.015 + 0.070 = 0.085\\ \\mathrm{mmol}\\ \\mathrm{min}^{-1}$\n\nSubstituting these values into the expression for $T$:\n$$ T = \\frac{1}{3.0 \\times 10^{-3}} \\ln\\left(\\frac{0.085}{0.070}\\right) $$\nThe units of the parameters result in $T$ being in minutes.\n$$ T \\approx \\frac{1}{0.003} \\ln(1.2142857...) $$\n$$ T \\approx 333.333... \\times 0.194156... $$\n$$ T \\approx 64.7187\\ \\mathrm{min} $$\nThe problem asks for the time $T$ in hours, rounded to three significant figures. To convert minutes to hours, we divide by $60$:\n$$ T_{\\mathrm{hours}} = \\frac{64.7187}{60} \\approx 1.078645\\ \\mathrm{hours} $$\nRounding to three significant figures, we get:\n$$ T \\approx 1.08\\ \\mathrm{hours} $$", "answer": "$$\n\\boxed{1.08}\n$$", "id": "4942712"}]}